Rapid Micro Reports Q2 Revenue Growth and Margin Expansion
Rapid Micro Biosystems reported 11% Q2 revenue growth to $8.1M and record gross margins. The company reaffirmed full-year guidance, highlighting strong recurring revenue and 200th system milestone.
View filing at SEC.gov →